ClearPoint advances LITT and OR expansions amid partner progress. Read here to know why we believe CLPT stock is an ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

The use of JAK vs TNF inhibitors shows no significant increase in the incidence of major adverse cardiovascular events in ...

A plain language summary for patients explains there were no differences in safety outcomes between adalimumab-adbm and the ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

Patients were in their early 50s on average, and some 80% were women. Nearly all were white (most participants were from Eastern Europe and Chile). Mean disease duration was about 8 years. DAS28-CRP ...

Presented at the annual meeting of the New England Surgical Society, Hanover, New Hampshire, September 5, 1941. Select the format you want to export the citation of this publication.